Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Sam Bowie was drafted before Michael Jordan. What’s your point?
Let’s not forget this of course
https://www.marketwatch.com/amp/story/guid/497DE63A-D963-11E8-BE5B-3DC99C186526
I think you are misunderstanding my point. Canada progressed , while we stateside fought California every step of the way up until the last 5 years or so. The head start was meant for where we are today. 20 years behind. Conversation is finally beginning to be taken seriously.....Long over due... just to be clear Hunch;) I think Canadians were underestimated. I don’t think the US really saw this coming. If one thing ACB has done is opened many eyes globally. Best is yet to come.
I agree there might be a sleeping giant stateside. What many do not realize is California has had a 20 year head start on Canada. Unfortunately federal laws have stifled the progress.
Hey got me amped too...SMH no info available to substantiate.
Every journey starts with the first step old friend.
Are we speaking of an oxymoron? Lol
Interesting to say the least
Sure looks like it see for yourself
Didn’t Cam take a drink from a coffee cup in that video? Where he says “what’s that?”
Remember my friend sometimes you have to eat chit to remember how good ice cream tastes. ;)
We are in a better situation than most might think.
Remember we are the only grow op that could handle the supply Coke would need. Well established grow op that is.
For those new to the board and long time guys It is important to remember there is nothing to compare this sector to. Analysts don’t know how to analyze this. It is a completely new “legal”industry. There will be bumps in the road.There are plenty of people who are for the green rush, look at all of us here. There are also very deep pocketed institutional investors that have rode big Pharma, beer and alcohol for decades. They are not going to make it easy for us. We are in a fight stateside so don’t be mistaken.
Here are the facts:
The science is there... they know it.
The shipping channels are there... they know it.
The medical benefits are there... they know it, and recreationally the lore is there as well.
I’ve been buying this stock since it was trading under a dollar. Never once have I thought of selling. ESPECIALLY NOW! We finally have a seat at the table. I am frustrated too, but I have learned something over the last 2.5 years with this co. Be patient. There is an end game. We are doing it the right way. We are the only company that is covered from “seed to sale”. We own every facet of our business. We own the most cutting edge technology in extraction. We even own the waste part of the business.
It is also important to not forget our investments in other companies as well. In closing We are solid guys, and will laugh about this 6 months from now. Good luck my friends.
Uncle Bud
Hey destroyer can you call them back? Let them know it would be an excellent for Christmas red and green. ;)
Can’t stop this train.
https://apple.news/A5fIDgxXLTB299-Kg2RGROQ
It’s not a comparison to Amazon. It is an exercise in the way real companies act or trade. To also say that it is all hype is ludicrous. 1 billion conservatively in Revs and strategic investments is far from hype. Just my .02
Try not to panic here guys. No stock goes straight up. We are on the precipice of something great. The ground level of a global giant in its Infancy. Let me repeat that The ground level. This is a buy hold buy more play guys.
Take this for example:
November 2007, AMZN:$91. November 2008, AMZN: $37.
October 2018, AMZN: $1788.00
We are solid.
Testicular fortitude gents.
All using the legal time frame loophole portraying no harm no foul.
I agree kind of, think about this...I personally have become an extraction expert over the past two years. I believe that tech is the future. With the amount of product(dry flower) it takes to produce extracts, 3-1 grams conservatively, the supposed network, and Oct 17th looming. I find it a little suspect to burn all that money. I lean more to something went wrong with quality of strains, decision was made not to taint quality and controlled destruction was done. Just my.02
Would make sense. That’s how we do it. Exciting times to say the least.
It’s just becoming more attractive... on CNBC, they were just talking about hedge funds that have under preformed... they will be on a mad dash to purchase stocks through year end starting next week. Logically why not ACB NYSE. All signs point to the phrase...”We will have our innings” said Cam. I believe we will.
GLTA
Could not agree more my friend. It is also important to remember we have acted like a hedge fund of sorts to this space. Our investments are also paying off quite nicely.
Absolutely Shacktown... growing pains are to be expected. Canada is setting the bar right now. It would be unrealistic to think there would not be a learning curve. It’s ground breaking. On a sidebar...What are your thoughts about the defensive state the market seems to be headed into. Cash is strong now. My opinion is we are poised for a great entry on NYSE. Money has to go somewhere. Plus we are getting lots of free press with the fear US cannabis companies are stoking about being left behind. Thoughts?
It would be unlikely for Aurora to be overstocked. Remember it’s not about selling flower. That is a small part of our sales. More profitable concentrates/tabs/Ticture/vape oils/cbd products/ and other delivery methods account for much of our sales. Plus global distribution in place already. My opinion is it won’t grow fast enough.
Lol... it was! But a really tall 400 pound guy isn’t fat!
I know we are on the same team... I just took offense by you saying I was deluding people... anyone that has interacted with me knows that is not my MO.
Not if you are the tallest amongst them.
Ok Brit... Public numbers today or as I stated 45 days ago does make us the 400 lb guy amongst 1000 pounders. Today is a different story. As our operations come online those numbers change quickly.
It’s not as black and white as “look at the numbers” is my point.
A lot but that isn’t the point here. This sector is technology and extraction driven. Smoking weed and getting high is the fun part of this. It is the delivery of medicine in many forms that will make this revolutionary.
My Math proves value. Time will prove you wrong. Gltu sir
Really dude??? Do you not realize we will be at 88,000,000.00 a month conservatively by beginning of Q2? Your inflationary formula is meaningless in 90 days. I don’t delude anyone. I am openminded. Prove me wrong.
Try this for math...
Price to sales ratios of the players in this space:
Tilray 980% x sales
Canopy 142% x sales
Cronos 513% x sales
GW Pharma 245% x sales
Now Aurora is 112% x sales
(Data from 45 days ago)
What this means Brit is Aurora is the value play, and not part of your bubble.
Math at its best.
We are not part of that bubble cedarcreek
Not one time during the hype did we spike like others. All are gains Have been modest and earned. We are the reason why some feel market is overpriced. We are a monster trading at a supreme value for the moment. Don’t be discouraged by today. It is a great day.
Let’s not forget their subsidiaries ;)
Pedanios GmbH
Urban Cultivator
Australis Capital Inc
CanvasRx Inc
H2 Biopharma Inc
Peloton Pharmaceuticals Inc
Aurora Larssen Projects Ltd
Larssen Ltd.
Aurora Cannabis Enterprises Inc
BC Northern Lights Enterprises Ltd
A happy Hunch usually makes for a happy bunch! I wish I was in Canada. Smh
The Facility being built for expansion is by Larrsen... which we own as well. Starting to see a pattern?;)
As a philosophy we have acquired just about every facet of production and sales. In June we purchased Anandia Labs.
Led by CEO and co-founder Jonathan Page, PhD, one of the industry’s most widely recognized cannabis experts, Anandia is considered the industry leader in science, genetics, and independent cannabis product testing. Dr. Page was the first scientist to sequence the cannabis genome and provide deep insights into the biosynthesis of cannabinoids and the interplay between cannabinoids and terpenes.
Anandia’s COO and co-founder, John Coleman, PhD, brings over 20 years of experience in drug research and commercialization as a natural product chemist. He previously worked in the biotech industry, most recently leading the team identifying new drug targets for the federally funded Centre for Drug Research and Development.
Anandia’s intellectual property (“IP”) includes the exclusive rights to a number of key genes in the cannabinoid pathway, as well as patents pending for genetic markers. The strength of Anandia’s expert staff, proprietary assets and know-how will provide Aurora with a very significant advantage in developing new cannabis cultivars. For instance, genome-based variety development and technological fortification can tailor metabolite (cannabinoid and terpene) profiles, improve disease resistance, enhance crop yield and optimize flowering time, and can be employed to develop specialized cultivars for oil production.
In advance of the forthcoming legalization of the adult use market and the significant associated growth, Anandia intends to expand its R&D, product testing, and product development facilities to meet both domestic and international demand, including the development of:
A 12,700 sq. ft. corporate head office, testing lab, R&D and tissue culture facility in Vancouver, British Columbia. This existing laboratory is undergoing security upgrades, with operations planned to coincide with legalization.
A unique, 22,500 sq. ft., Aurora Larssen Projects Inc. (“ALP’s”) designed and constructed, Cannabis Innovation Centre, focused on cannabis breeding and genetics. This purpose-built greenhouse with an associated 10,000 sq. ft. laboratory building in Comox, BC is currently under construction and is located five minutes from a major airport, and has the option to expand to 100,000+ sq. ft. The project is on track with development permitting in-place, and construction planned for summer/fall 2018.
Anandia follows a three-pronged approach to creating value for its clients licensed under Canada’s Access to Cannabis for Medical Purposes Regulations (“ACMPR”) and intends to continue to do so following completion of the Transaction:
Independent Third-Party Analytical Testing: which includes cannabinoids, terpenes and contaminants (microorganisms, pesticides, heavy metals and others).
Genetics: plant breeding, tissue culture and strain archiving, as well as genomics-based technologies.
Product Development: development of cannabinoid preparations and formulations.
Combining with Aurora gives Anandia access to significant new market opportunities in Canada and internationally through Aurora’s global footprint. Furthermore, leveraging Aurora’s capabilities and capacity in facility development, the combination will accelerate the construction of Anandia’s testing and product development laboratory in Vancouver, and a unique, purpose-built cannabis breeding facility ahead of Canadian adult-use legalization,
Anandia’s Product Testing
Anandia’s cannabis testing services will remain operationally independent of Aurora. These services will remain intact and Anandia is committed to continuing to serve all clients, including Licensed Producers and patient-growers, and Anandia is committed to maintaining complete data confidentiality. Anandia will continue to build capacity to take on the increased sample volume arising from legalization, including expansion to its new testing facility in Vancouver.
From seed to sale. That’s the philosophy